In recent years, as doctors have continued to switch diabetic patients to a new class of diabetes drugs, which includes the blockbuster medications Januvia, Victoza and Byetta, increasing evidence has emerged suggesting a link between use of the drugs and an increased risk of pancreatic cancer. However, serious concerns exist about the lack of research conducted by the drug makers and the failure to provide adequate information about the potential risk for consumers and the medical community. […]
Amid concerns that Byetta, Januvia and other incretin mimetic diabetes drugs may cause pancreatic cancer, pancreatitis, thyroid cancer and other injuries, a growing number of health experts and consumer advocates are calling for the drugs to be recalled from the market, as any potential benefits appear to be outweighed by the risks. […]
A motion has been filed to consolidate all Byetta lawsuits, Victoza lawsuits, Januvia lawsuits and Janumet lawsuits brought throughout the federal court system on behalf of individuals who developed pancreatic cancer after using any of the diabetes drugs, asking a panel of federal judge to centralize the cases in one court for coordinated handling as part of an MDL, or Multi-District Litigation. […]
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Byetta cancer lawsuits, Januvia cancer lawsuits and Victoza cancer lawsuits for users of the popular diabetes drugs who have been diagnosed with pancreatic cancer.
Financial compensation may be available as a result of the drug makers’ failure to fully research the side effects of Byetta, Januvia and Victoza, or adequately warn about the risk of problems that may lead to the eventual diagnosis of cancer. […]